We investigated prospectively the effect of sex steroids on regional fat depots and thigh muscle mass in adult transsexuals. Ethinyl estradiol in combination with cyproterone acetate, a progestational antiandrogen, was given to 20 male-to-female (M-F) transsexuals, and parenteral testosterone esters were given to 17 female-to-male (F-M) transsexuals. Before and after 12 mo of cross-sex hormone administration, several anthropometric measurements (weight, skinfolds, body circumferences, and bioimpedance) were performed, and transverse magnetic resonance images were obtained at the level of the abdomen, hip, and thigh to quantify fat depots (subcutaneous and visceral) and muscle areas. We observed that treatment with ethinyl estradiol in M-F t...
Sex steroids are important determinants of bone acquisition and bone homeostasis. Cross-sex hormonal...
Abstract Obesity is one of the most invaliding and preventable diseases in the United States. Growin...
Weight gain and body fat increase the risk of cardiometabolic disease. Cross-sex hormone therapy in ...
We prospectively studied the effects of cross-sex hormone administration on fat cell size and in vit...
The amount of intraabdominal (visceral) fat is an important determinant of disturbances in lipid and...
The amount of intraabdominal (visceral) fat is an important determinant of disturbances in lipid and...
Main findings In chapter 2 we showed that estrone concentrations are not associated with change in b...
Objective Cross-sex hormonal therapy (CHT) in trans persons affects their total body fat and total l...
Men and women are different in their fat mass and distribution pattern. The gynoid-type fat distribu...
Although trans women before the start of hormonal therapy have a less bone and muscle mass compared ...
objective Sex differences are found in most components of the insulin resistance syndrome and the as...
Objective: Cross-sex hormonal therapy (CHT) in trans persons affects their total body fat and total ...
In 70 healthy obese subjects (37 men and 33 premenopausal women; aged 27-51 yr; body mass index, 28-...
INTRODUCTION: Excess visceral fat increases the risk of type 2 diabetes and cardiovascular disease a...
Chronic pain is gender-related, since there is a clear predominance of one sex with respect to the o...
Sex steroids are important determinants of bone acquisition and bone homeostasis. Cross-sex hormonal...
Abstract Obesity is one of the most invaliding and preventable diseases in the United States. Growin...
Weight gain and body fat increase the risk of cardiometabolic disease. Cross-sex hormone therapy in ...
We prospectively studied the effects of cross-sex hormone administration on fat cell size and in vit...
The amount of intraabdominal (visceral) fat is an important determinant of disturbances in lipid and...
The amount of intraabdominal (visceral) fat is an important determinant of disturbances in lipid and...
Main findings In chapter 2 we showed that estrone concentrations are not associated with change in b...
Objective Cross-sex hormonal therapy (CHT) in trans persons affects their total body fat and total l...
Men and women are different in their fat mass and distribution pattern. The gynoid-type fat distribu...
Although trans women before the start of hormonal therapy have a less bone and muscle mass compared ...
objective Sex differences are found in most components of the insulin resistance syndrome and the as...
Objective: Cross-sex hormonal therapy (CHT) in trans persons affects their total body fat and total ...
In 70 healthy obese subjects (37 men and 33 premenopausal women; aged 27-51 yr; body mass index, 28-...
INTRODUCTION: Excess visceral fat increases the risk of type 2 diabetes and cardiovascular disease a...
Chronic pain is gender-related, since there is a clear predominance of one sex with respect to the o...
Sex steroids are important determinants of bone acquisition and bone homeostasis. Cross-sex hormonal...
Abstract Obesity is one of the most invaliding and preventable diseases in the United States. Growin...
Weight gain and body fat increase the risk of cardiometabolic disease. Cross-sex hormone therapy in ...